LifeStance's visits rose 17%. Why did profit grow so much faster?
More clinicians, higher productivity and better reimbursement rates helped the mental-health provider exceed its original forecast. The gain also reaches reported earnings and cash flow.
LifeStance's clinicians are handling more visits, and each visit is bringing in more revenue. Those gains are lifting profit faster than the cost of running its outpatient mental-health network.
Q3 revenue rose 25% to $455.9 million, while adjusted EBITDA increased 70% to $68.4 million. The improvement also showed up in reported operating income, which rose to $33.1 million from $7.4 million.
What turned more visits into more profit
The network's clinician count grew 11% from a year earlier to 8,863. Visit volume rose 17%, helped by both a larger workforce and better clinician productivity. Revenue per visit increased to $169.70 from $158.20, which management attributed primarily to higher insurance reimbursement rates.
Center costs and corporate overhead each grew about 19%, slower than sales. That left more of the additional revenue as operating profit, even as LifeStance spent more on staffing, marketing, technology and its expanding footprint.
Acquisitions contributed too. LifeStance bought four outpatient practices during the first nine months, so the reported growth combines hiring, productivity, pricing and acquired operations.
The original forecast was lower
In August, management expected Q3 revenue of $420 million to $440 million and adjusted EBITDA of $49 million to $59 million. Both actual results exceeded those upper limits.
Research by Ticker Byline shows that quarterly adjusted EBITDA finished $9.4 million above the top of that original range. Management has now raised its annual target to $242 million to $250 million from $215 million to $235 million.
The latest Q4 forecast calls for $56 million to $64 million of adjusted EBITDA on revenue of $446 million to $466 million. That profit range sits below Q3's result, even as its revenue range straddles the latest quarter.
The improvement reaches cash flow
Operating cash flow for the first nine months rose to $170.0 million from $88.6 million. After cash capital spending, $132.6 million remained, compared with $63.4 million a year earlier. Improved profit and less cash tied up in operating balances both helped.
Adjusted EBITDA excludes interest, taxes, depreciation, amortization, stock-based pay and selected other expenses. Quarterly stock compensation was broadly unchanged at $18.2 million, so a larger exclusion of that cost did not drive the profit increase. GAAP net income rose to $22.4 million from $1.1 million.
The next operating test is whether continued hiring and higher revenue per visit can keep spreading overhead across a larger business. Our LifeStance company profile tracks the quarterly record, revised targets, completed acquisitions, cash use and debt.